expanding-access-to-sickle-cell-gene-therapies-for-patients-with-medicaid

Connecticut is engaging in a novel federal initiative that links compensation for sickle cell therapies to their effectiveness in patients, with the objective of providing treatment to a larger population.


Leave a Reply

Your email address will not be published. Required fields are marked *

Share This